Skip to main content

A PHASE 2/3 RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED TRIAL OF QPI-1007 DELIVERED BY SINGLE OR MULTI-DOSE INTRAVITREAL INJECTIONS TO SUBJECTS WITH ACUTE NON ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY (NAION)

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Quark Pharmaceuticals, Inc

Start Date

June 15, 2015

End Date

June 14, 2021
 

Administered By

Ophthalmology

Awarded By

Quark Pharmaceuticals, Inc

Start Date

June 15, 2015

End Date

June 14, 2021